32 results
8-K/A
EX-99.1
ELTX
Elicio Therapeutics Inc.
11 Aug 23
Elicio Therapeutics, Inc. Financial Statements
9:13pm
registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company
8-K
EX-10.13
r4gptf6k1bn
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
8-K
EX-99.3
73nlcy wx6ous
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
8-K
EX-99.4
dkbtzmr hqf9eiyl4
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
424B3
yo0 m8vzxj7eqxxuv
28 Apr 23
Prospectus supplement
4:07pm
S-4/A
3w08d2 ipqquog1rqbyb
29 Mar 23
Registration of securities issued in business combination transactions (amended)
5:29pm
S-4/A
EX-10.33
t4y4vy
29 Mar 23
Registration of securities issued in business combination transactions (amended)
5:29pm
DEF 14A
62v9ql0ew5if7yht
27 Apr 22
Definitive proxy
4:04pm